Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Results 1 - 20 of 49 : 1 2 3 Next »

Recs

0
Member Avatar NechesInvst (99.66) Submitted: 6/19/2015 11:17:33 AM : Outperform Start Price: $230.93 VRX Score: -1.78

Just checking to see if Bill Ackman can pick growth companies.

Recs

0
Member Avatar stocky5 (40.57) Submitted: 6/18/2015 10:00:17 AM : Outperform Start Price: $232.34 VRX Score: -2.10

Forward PEG is 0.67 (CHEAP), with a forward growth rate of over 27%. The stock is near oversold levels, creating a good entry point. Extremely well run company with strong shareholder friendly activist oversight.

Recs

0
Member Avatar luremaster (41.44) Submitted: 5/8/2015 3:57:19 AM : Outperform Start Price: $221.42 VRX Score: +2.06

great management

Recs

0
Member Avatar AnsgarJohn (98.51) Submitted: 5/5/2015 9:00:44 AM : Underperform Start Price: $219.85 VRX Score: -2.16

http://fortune.com/2015/05/04/bill-ackman-valeant-could-be-next-berkshire-hathaway/

Recs

0
Member Avatar moneyman999 (47.19) Submitted: 2/15/2015 1:44:00 AM : Underperform Start Price: $168.17 VRX Score: -32.88

Simply overvalued,volitilty will be high but gains will be low.

Recs

0
Member Avatar freecapital (75.48) Submitted: 2/10/2015 11:37:21 PM : Outperform Start Price: $162.74 VRX Score: +35.93

Donville

Recs

0
Member Avatar 10x2 (47.00) Submitted: 1/30/2015 8:17:37 PM : Outperform Start Price: $158.00 VRX Score: +37.53

Sabrient pick.

Recs

0
Member Avatar reddingrunner (95.63) Submitted: 1/16/2015 1:33:28 PM : Outperform Start Price: $155.58 VRX Score: +39.11

sabrient bakers dozen 2015

Recs

0
Member Avatar 1russianguy (64.11) Submitted: 1/15/2015 9:17:14 AM : Outperform Start Price: $158.00 VRX Score: +37.53

Sabrient

Recs

0
Member Avatar mrudolph72 (60.94) Submitted: 1/14/2015 3:10:34 PM : Outperform Start Price: $157.00 VRX Score: +37.78

Sabrient

Recs

0
Member Avatar Defshark82 (77.07) Submitted: 12/31/2014 11:46:13 AM : Outperform Start Price: $143.88 VRX Score: +54.29

top pick JPM tracker

Recs

0
Member Avatar mlarms (< 20) Submitted: 7/31/2014 2:24:29 AM : Outperform Start Price: $118.88 VRX Score: +80.28

My big Pharma pick

Recs

0
Member Avatar chipotlepickle (97.73) Submitted: 6/15/2014 5:21:26 PM : Underperform Start Price: $118.81 VRX Score: -79.46

Running out of one time events.

Recs

0
Member Avatar ValueSwap (< 20) Submitted: 6/12/2014 3:29:27 PM : Outperform Start Price: $120.02 VRX Score: +77.30

How R&D should work and their aggressive capitalizing interest to generate a low tax rate create much fuzz about the company, which in turn give a long term holder a good entry point

Recs

0
Member Avatar IanERichards (87.08) Submitted: 6/4/2014 7:37:57 AM : Outperform Start Price: $131.15 VRX Score: +61.23

Focus on capital allocation - creative approach to making a deal

Recs

0
Member Avatar RickP (91.61) Submitted: 5/18/2014 6:17:33 PM : Outperform Start Price: $125.85 VRX Score: +65.58

Great CEO......

Fantastic future regardless of whether Allergen merger occurs or not

Recs

0
Member Avatar RLBOWERSOX (93.41) Submitted: 3/31/2014 4:40:45 PM : Outperform Start Price: $132.07 VRX Score: +57.30

One of the final four

Recs

0
Member Avatar mrwrong (< 20) Submitted: 3/29/2014 2:06:48 PM : Underperform Start Price: $129.27 VRX Score: -60.34

growth will stall as company comes a cropper, with a bridge too far. most all- do, but i like it now.

Recs

0
Member Avatar motto1628 (51.08) Submitted: 3/25/2014 4:05:57 PM : Outperform Start Price: $132.26 VRX Score: +56.71

- genius CEO in acquisition
- diversified pharmaceutical products
- stock advisor pick

Recs

0
Member Avatar mtbound (43.29) Submitted: 3/1/2014 12:25:37 PM : Outperform Start Price: $143.30 VRX Score: +42.49

I'm here mainly because of leadership. I've bought in to extraordinary leadership extracting value.

Results 1 - 20 of 49 : 1 2 3 Next »

Featured Broker Partners


Advertisement